Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5K7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,579
Award facts
- Contract value 100% obligated
- $13,578.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,578.60 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count packaging). The contract, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in supply chain solutions for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract represents a strategic vehicle that provides flexible access to essential pharmaceutical products required by the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJ5K7?
SPE2DR26FJ5K7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJ5K7 worth?
The government has obligated $13,579 on SPE2DR26FJ5K7.
Is contract SPE2DR26FJ5K7 an order under another contract?
Yes. SPE2DR26FJ5K7 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5K7 competed?
The extent of competition for SPE2DR26FJ5K7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award